🚀 Are you degen trader that's down 50% on a MindMed yolo? &nbsp;I'm your stock therapist and I'm here to help you understand your emotions. &nbsp;In this video I go over some basic behavioral economic concepts (like utility theory, risk aversion and risk seeking) and demonstrate how they apply to the psychology of traders using MindMed as a case study. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
 
Questions answered:&nbsp;
<ul>
 <li>What should MindMed investors do now that they're 50% below the highs?&nbsp;</li>
 <li>Why are emotions so much higher with meme stocks?&nbsp;</li>
 <li>Why do we get more skittish as stocks climb higher?&nbsp;</li>
 <li>Why do losses after big wins bother us more than losses after small wins?&nbsp;</li>
 <li>How can we be more rational investors? &nbsp;&nbsp;</li>
</ul>
 
Watch the vid @ https://youtube.com/c/bromtalks

10:  Shroom Stock Research: 10 Questions to Ask Before Buying Psychedelic Stocks like MindMed and Compass

The Integration Conversation covers the emerging psychedelic industry. Watch as Hedge Fund veteran and psychedelic enthusiast Brom interviews psychedelic CEOs, performs in-depth analysis of psychedelic companies, and discusses the implications of psychedelics on our society. 

Prior to starting the Integration Conversation, Brom spent 7 years as a quant at multiple hedge funds.  Brom is a CFA charterholder and holds an MS in CS with a focus on Machine Learning from Georgia Tech.  In addition to running the Integration Conversation, Brom is focused on angel investing in psychedelic startups.